Istituto Oncologico Veneto Irccs

This study looked at how safe and effective the drug Cabozantinib is for people aged 70 and older with advanced kidney cancer. Researchers tracked side effects and tumor response in 100 participants. The goal was to see if this treatment works well in older patients who have alre…

This early-phase trial tested adding the targeted drug regorafenib to standard chemotherapy (temozolomide) with or without radiation for people with a newly diagnosed, aggressive type of brain cancer called glioblastoma. The study involved 21 participants and aimed to find the sa…

This Phase 3 trial tested whether the immunotherapy drug avelumab, given after standard treatments like surgery and chemotherapy, can help prevent breast cancer from coming back in people with high-risk triple negative breast cancer. The study enrolled 474 participants who had al…

This study looked back at medical records of over 1,000 people with rare breast conditions called florid and pleomorphic lobular carcinoma in situ (FLCIS and PLCIS). The goal was to understand how doctors currently diagnose and treat these conditions, since there are no official …